| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d3dadeff9700f94510f14e08743a4ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_329457e95aaa93e43adbbfe627ddb593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9a023366f837434161a8af760773743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03b7777e71e63aae8f28ba9fc97268b7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 |
| filingDate |
2005-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be6df0ae69fb64af6a1d07968f07a6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3fc7d436542e96a6aa8d9e0ffa49087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c8386fc03d35d75cba4baf220bffed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b373c1c88ae2ab7b46942ba6ba1f10fa |
| publicationDate |
2006-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006063705-A1 |
| titleOfInvention |
Use of alpha-MSH and EPO for preventing or treating ischemic conditions |
| abstract |
Alpha-melanocyte stimulating hormone (α-MSH) or an equivalent is used, in conjunction with erythropoietin (EPO) or equivalent, to prevent or treat ischemic conditions. |
| priorityDate |
2000-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |